 Impaired thrombotic status is associated with adverse cardiovascular events. Patients with acute coronary syndrome ACS are at increased cardiovascular risk. The aim of the study is to determine the usefulness of thrombotic status assessment in a large cohort of ACS patients, managed with contemporary treatments, to identify patients at risk of thrombosis and those at risk of bleeding complications. 